Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

Ford, Alexander C, Quigley, Eamonn M M, Lacy, Brian E, Lembo, Anthony J, Saito, Yuri A, Schiller, Lawrence R, Soffer, Edy E, Spiegel, Brennan M R, Moayyedi, Paul·2014·American Journal of Gastroenterology
DOI 10.1038/ajg.2014.148

Cited by (405)

Items 101–200 of 405

  1. Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial
    Pui Kuan Cheong, Alexander Charles Ford, Cynthia Cheung, Jessica Yuet–Ling Ching, Yawen Chan, Joseph J.�Y. Sung, Francis K.L. Chan, Justin C. Y. Wu · 2018 · The Lancet. Gastroenterology & hepatology
  2. The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease
    Carmelo Scarpignato, Richard H. Hunt · 2019 · Current Opinion in Gastroenterology
  3. Antidepressants for irritable bowel syndrome—A systematic review
    Agnieszka Kułak-Bejda, Grzegorz Bejda, Napoleon Waszkiewicz · 2017 · Pharmacological Reports
  4. Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study
    Agger, Johanne L, Schröder, Andreas, Gormsen, Lise K, Jensen, Jens S, Jensen, Troels S, Fink, Per K · 2017 · The Lancet Psychiatry
  5. Gut feelings: the relations between depression, anxiety, psychotropic drugs and the gut microbiome
    Siobhan Brushett, Ranko Gaćeša, Arnau Vich Vila, Milla F. Brandao Gois, Sergio Andreu‐Sánchez, Johann Casper Swarte, Marjolein A. Y. Klaassen, Valerie Collij, Trishla Sinha, Laura A. Bolte et al. · 2023 · Gut Microbes
  6. Hypnotherapy for Esophageal Disorders
    Megan E. Riehl, Laurie Keefer · 2015 · American Journal of Clinical Hypnosis
  7. Chronic constipation: Update on management
    Umar Hayat, Mohannad F. Dugum, Samita Garg · 2017 · Cleveland Clinic Journal of Medicine
  8. Irritable Bowel Syndrome: Modern Concepts and Management Options
    Gregory S. Sayuk, Chandra Prakash Gyawali · 2015 · The American Journal of Medicine
  9. Systematic review with meta‐analysis: online psychological interventions for mental and physical health outcomes in gastrointestinal disorders including irritable bowel syndrome and inflammatory bowel disease
    Inna Hanlon, Catherine Elizabeth Hewitt, Kerry Jane Bell, A. Phillips, Antonina A Mikocka‐Walus · 2018 · Alimentary Pharmacology & Therapeutics
  10. Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea
    Hui Zheng, Ying Li, Wei Zhang, Fang Zeng, Siyuan Zhou, Huabin Zheng, Wenzeng Zhu, Xiang‐Hong Jing, Peijing Rong, Chunzhi Tang et al. · 2016 · Medicine
  11. Pharmacotherapy for Irritable Bowel Syndrome
    Michael Camilleri, Alexander Charles Ford · 2017 · Journal of Clinical Medicine
  12. Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice
    Susan L. Lucak, Lin Chang, Albena D. Halpert, Lucinda A. Harris · 2016 · Therapeutic Advances in Gastroenterology
  13. Integrative Medicine for Gastrointestinal Disease
    Michelle L. Dossett, Ezra M. Cohen, Jonah Cohen · 2017 · Primary Care Clinics in Office Practice
  14. A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD)
    Edoardo Vincenzo Savarino, Patrizia Zentilin, Elisa Marabotto, Giorgia Bodini, Marco Della Coletta, Marzio Frazzoni, Nicola de Bortoli, Irene Martinucci, Salvatore Tolone, Gaia Pellegatta et al. · 2017 · Expert Opinion on Pharmacotherapy
  15. The Influence of Antidepressants on the Disease Course Among Patients With Crohn’s Disease and Ulcerative Colitis—A Danish Nationwide Register–Based Cohort Study
    Marie Skov Kristensen, Thora Majlund Kjærulff, Annette Kjær Ersbøll, Anders Green, Jesper Hallas, Lau Caspar Thygesen · 2018 · Inflammatory Bowel Diseases
  16. Discriminant and convergent validity of the GSRS‐IBS symptom severity measure for irritable bowel syndrome: A population study
    Ljótsson, Brjánn, Jones, Michael, Talley, Nicholas J, Kjellström, Lars, Agréus, Lars, Andreasson, Anna · 2020 · United European Gastroenterology Journal
  17. Clinical practice guidelines for irritable bowel syndrome in Korea, 2017 revised edition
    Song, Kyung Ho, Jung, Hye-Kyung, Kim, Hyun Jin, Koo, Hoon Sup, Kwon, Yong Hwan, Shin, Hyun Duk, Lim, Hyun Chul, Shin, Jeong Eun, Kim, Sung Eun, Cho, Dae Hyeon et al. · 2018 · Journal of Neurogastroenterology and Motility
  18. Irritable bowel syndrome: new and emerging treatments
    M. Halland, Y. Saito · 2015 · British medical journal
  19. Irritable Bowel Syndrome
    S. Sultan, A. Malhotra · 2017 · Annals of Internal Medicine
  20. Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
    Esther Colomier, Joost P. Algera, Chloé Melchior · 2021 · Frontiers in Pharmacology
  21. New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists
    Amy E. Foxx–Orenstein · 2016 · Therapeutic Advances in Gastroenterology
  22. Key mechanisms of cognitive behavioural therapy in irritable bowel syndrome: The importance of gastrointestinal related cognitions, behaviours and general anxiety
    Sula Windgassen, Rona E Moss-Morris, Kimberley Goldsmith, Trudie Chalder · 2018 · Journal of Psychosomatic Research
  23. Asia‐Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms
    Kok‐Ann Gwee, Yeong Yeh Lee, Hidekazu Suzuki, Uday C. Ghoshal, Gerald Holtmann, Tao Bai, Giovanni Barbara, Minhu Chen, Andrew Seng Boon Chua, Peter R. Gibson et al. · 2022 · Journal of Gastroenterology and Hepatology
  24. The Management of Paediatric Functional Abdominal Pain Disorders: Latest Evidence
    Andrea Brusaferro, Edoardo Farinelli, Letizia Zenzeri, Rita Cozzali, Susanna Esposito · 2018 · Pediatric Drugs
  25. Is there a causal link between psychological disorders and functional gastrointestinal disorders?
    Mira M. Wouters, Guy E. Boeckxstaens · 2015 · Expert Review of Gastroenterology & Hepatology
  26. Emerging treatments in neurogastroenterology: eluxadoline – a new therapeutic option for diarrhea‐predominant IBS
    Brian E. Lacy · 2015 · Neurogastroenterology & Motility
  27. Pharmacologic, Pharmacokinetic, and Pharmacogenomic Aspects of Functional Gastrointestinal Disorders
    Michael Camilleri, Lionel P. Bueno, Viola Andresen, Fabrizio De Ponti, Myung‐Gyu Choi, Anthony J Lembo · 2016 · Gastroenterology
  28. Cognitive Behavioral Therapy for IBS: How Useful, How Often, and How Does It Work?
    Christopher D. Radziwon, Jeffrey M. Lackner · 2017 · Current Gastroenterology Reports
  29. Insights into the evaluation and management of dyspepsia: recent developments and new guidelines
    Christopher J. Black, Lesley Anne Houghton, Alexander Charles Ford · 2018 · Therapeutic Advances in Gastroenterology
  30. Implementing psychological therapies for functional GI disorders in children and adults
    Bonney Reed, Robyn Lewis Claar, Jennifer V. Schurman, Miranda A.L. van Tilburg · 2016 · Expert Review of Gastroenterology & Hepatology
  31. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease
    Antonina A Mikocka‐Walus, Andrea Louise Fielder, Stephanie Louise Prady, Adrian Esterman, Simon Robert Knowles, Jane Mary Andrews · 2017 · Cochrane Database of Systematic Reviews
  32. The Role of Resilience in Irritable Bowel Syndrome, Other Chronic Gastrointestinal Conditions, and the General Population
    Colleen H. Parker, Bruce D. Naliboff, Wendy Shih, Angela P. Presson, Lisa Ann Kilpatrick, Arpana Gupta, Cathy Liu, Laurie Keefer, Jenny S. Sauk, Robert P. Hirten et al. · 2020 · Clinical Gastroenterology and Hepatology
  33. Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis
    Jason A Hawrelak, Hans Wohlmuth, Martina Pattinson, Stephen P Myers, Joshua Z. Goldenberg, Joanna Harnett, Kieran Cooley, Claudine Van De Venter, Rebecca Reid, Dawn L. Whitten · 2019 · Complementary Therapies in Medicine
  34. Irritable bowel syndrome: diagnosis and management
    Imke Masuy, Jasper Pannemans, Jan F. Tack · 2020 · Minerva Gastroenterologica e Dietologica
  35. A meta-analysis and systematic review of the comorbidity between irritable bowel syndrome and bipolar disorder
    Ping‐Tao Tseng, Bing‐Syuan Zeng, Yen‐Wen Chen, Ming‐Kung Wu, Ching-Kuan Wu, Pao‐Yen Lin · 2016 · Medicine
  36. Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS‐D) and IBS mixed pattern (IBS‐M)
    Judy W. Nee, Anthony J Lembo · 2021 · Alimentary Pharmacology & Therapeutics
  37. Low-FODMAP Diet for Irritable Bowel Syndrome: Is It Ready for Prime Time?
    Muhammad Ali Khan, Salman Nusrat, Muhammad Imran Khan, Ali T. Nawras, Klaus Bielefeldt · 2014 · Digestive Diseases and Sciences
  38. IBS-like symptoms in patients with ulcerative colitis
    David J. Gracie, Alexander Charles Ford · 2015 · Clinical and Experimental Gastroenterology
  39. Advances in IBS 2016: A Review of Current and Emerging Data.
    Ira M Jacobson · 2016 · PubMed Central
  40. Review article: an analysis of safety profiles of treatments for diarrhoea‐predominant irritable bowel syndrome
    B. Lacy · 2018 · Alimentary Pharmacology and Therapeutics
  41. Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder
    Jasmine Turna, Keren Grosman Kaplan, Beth A. Patterson, Přemysl Berčík, Rebecca Anglin, Noam Soreni, Michael Van Ameringen · 2019 · Journal of Psychiatric Research
  42. Association between gastrointestinal symptoms and affectivity in patients with bipolar disorder
    Pontus Karling, Martin Maripuu, Mikael Wikgren, Rolf Adolfsson, Karl‐Fredrik Norrback · 2016 · World Journal of Gastroenterology
  43. New psychological therapies for irritable bowel syndrome: Mindfulness, acceptance and commitment therapy (ACT)
    Sebastián Sánchez, Beatriz, Gil Roales-Nieto, Jesús, Ferreira, Nuno Bravo, Gil Luciano, Bárbara, Sebastián Domingo, Juan José · 2017 · Revista Espanola de Enfermedades Digestivas
  44. Negative Events During Adulthood Are Associated With Symptom Severity and Altered Stress Response in Patients With Irritable Bowel Syndrome
    Colleen H. Parker, Bruce D. Naliboff, Wendy Shih, Angela P. Presson, Elizabeth Jane Videlock, Emeran A. Mayer, Lin Chang · 2019 · Clinical Gastroenterology and Hepatology
  45. Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome
    J. Kane, A. Ford · 2016 · Expert Review of Gastroenterology & Hepatology
  46. Recent Advances in Pain Management: Relevant Protein Kinases and Their Inhibitors
    Francis Giraud, Elisabeth Pereira, Fabrice Anizon, Pascale Moreau · 2021 · Molecules
  47. Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.
    M. Camilleri, A. Ford · 2017 · Handbook of Experimental Pharmacology
  48. Systematic review, meta-analysis with subgroup analysis of hypnotherapy for irritable bowel syndrome, effect of intervention characteristics
    Krouwel, Matthew, Farley, Amanda, Greenfield, Sheila, Ismail, Tariq, Jolly, Kate · 2021 · Complementary Therapies in Medicine
  49. Integrated medical–psychiatric outpatient care in functional gastrointestinal disorders improves outcome
    Joanna W. Kruimel, Carsten Leue, Björn Winkens, Dagmar Marcus, Sam Schoon, Romy Dellink, Jim van Os, Ad Masclee · 2015 · European Journal of Gastroenterology & Hepatology
  50. Beliefs About GI Medications and Adherence to Pharmacotherapy in Functional GI Disorder Outpatients
    Benjamin E. Cassell, Chandra Prakash Gyawali, Vladimir M. Kushnir, Britt M. Gott, Billy Darren Nix, Gregory S. Sayuk · 2015 · The American Journal of Gastroenterology
  51. Targeting tachykinin receptors for the treatment of functional gastrointestinal disorders with a focus on irritable bowel syndrome
    Maura Corsetti, Filiz Akyüz, Jan F. Tack · 2015 · Neurogastroenterology & Motility
  52. What the public think about hypnosis and hypnotherapy: A narrative review of literature covering opinions and attitudes of the general public 1996–2016
    Matthew Krouwel, Kate B Jolly, Sheila Greenfield · 2017 · Complementary Therapies in Medicine
  53. Longitudinal follow-up study: Effect of psychological co-morbidity on the prognosis of inflammatory bowel disease
    Fairbrass, Keeley M., Gracie, David J., Ford, Alexander C. · 2021 · Alimentary Pharmacology & Therapeutics
  54. Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating
    Ringel-Kulka, Tamar, McRorie, Johnson, Ringel, Yehuda · 2017 · American Journal of Gastroenterology
  55. Global research trends in the microbiome related to irritable bowel syndrome: A bibliometric and visualized study
    Sa’ed H. Zyoud, Simon Smale, W. Stephen Waring, Waleed M. Sweileh, Samah W. Al‐Jabi · 2021 · World Journal of Gastroenterology
  56. Sphincter of Oddi dysfunction Type III: New studies suggest new approaches are needed
    C. Mel Wilcox · 2015 · World Journal of Gastroenterology
  57. The potential role of behavioral therapies in the management of centrally mediated abdominal pain
    Laurie Keefer, S. Mandal · 2014 · Neurogastroenterology & Motility
  58. Anhedonia in irritable bowel syndrome and in inflammatory bowel diseases and its relationship with abdominal pain
    Luna Carpinelli, Cristina Bucci, Antonella Santonicola, Fabiana Zingone, Carolina Ciacci, Paola Iovino · 2019 · Neurogastroenterology & Motility
  59. Depression and Structural Factors Are Associated With Symptoms in Patients of Irritable Bowel Syndrome With Diarrhea
    Jia Yi Lu, Lili Shi, Dan Huang, Wenjuan Fan, Xiaoqing Li, Liming Zhu, Jing Wei, Xiucai Fang · 2020 · Journal of Neurogastroenterology and Motility
  60. Gene Expression Profiling and Assessment of Vitamin D and Serotonin Pathway Variations in Patients With Irritable Bowel Syndrome
    Christopher M. Dussik, Maryam Hockley, Aleksandra Grozić, Ichiro Kaneko, Lin Zhang, Marya S. Sabir, Jin Kee Park, Jie Wang, Cheryl A. Nickerson, Steven Howard Yale et al. · 2018 · Journal of Neurogastroenterology and Motility
  61. Cognitive‐behavioural therapy in patients with inflammatory bowel diseases: A systematic review and meta‐analysis
    Chenyang Li, Zhenhua Hou, Yanhui Liu, Yu-Nan Ji, Lingli Xie · 2018 · International Journal of Nursing Practice
  62. Efficacy of gut–brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis
    Mais Khasawneh, Marjan Mokhtare, Paul Moayyedi, Christopher J. Black, Alexander Charles Ford · 2025 · The Lancet. Gastroenterology & hepatology
  63. Hypnotherapy for Inflammatory Bowel Disease Across the Lifespan
    Eva Szigethy · 2015 · American Journal of Clinical Hypnosis
  64. Lactobacillus plantarum PS128 Ameliorated Visceral Hypersensitivity in Rats Through the Gut–Brain Axis
    Yen-Wenn Liu, Yen‐Po Wang, Hsu-Fang Yen, Pei-Yi Liu, Wen-Jian Tzeng, Chia-Fen Tsai, Han‐Chieh Lin, Fa‐Yauh Lee, One-Jang Jeng, Ching‐Liang Lu et al. · 2019 · Probiotics and Antimicrobial Proteins
  65. Digestive promoting effect and mechanism of Jiao Sanxian in rats
    Ying Liu, Wenting Liao, Xingran Liu, Yun-Wei Hu, Xiaoxia Zhu, Longtao Ju, Feng Feng, Wei Qu, Wenyuan Liu, Jian Xu · 2021 · Journal of Ethnopharmacology
  66. Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
    R. Vázquez-Frías, Alejandra Consuelo‐Sánchez, Carlos Patricio Acosta-Rodríguez-Bueno, Andrés Blanco-Montero, Daniel Casas Robles, Vanessa Cohen, Daniel Márquez, Marcos III Perez · 2022 · Pediatric Drugs
  67. Chronic constipation: from pathophysiology to management
    Giovanni Barbara, Maria Raffaella Barbaro, Giovanni Marasco, Cesare Cremon · 2023 · Minerva Gastroenterology
  68. Management of Chronic Visceral Pain
    Anne Estrup Olesen, Adam Donald Farmer, Søren Schou Olesen, Qasim Aziz, Asbjørn Mohr Drewes · 2016 · Pain Management
  69. American college of gastroenterology monograph on the management of irritable bowel syndrome
    Michael Camilleri · 2015 · Expert Opinion on Pharmacotherapy
  70. Chronic continuous abdominal pain: evaluation of diagnostic features, iatrogenesis and drug treatments in a cohort of 103 patients
    Kilgallon, Eleesia, Vasant, Dipesh H., Green, Darren, Shields, Philip L., Hamdy, Shaheen, Lal, Simon, Paine, Peter · 2019 · Alimentary Pharmacology & Therapeutics
  71. A randomized clinical trial of the Unified Protocol for Transdiagnostic treatment of emotional and gastrointestinal symptoms in patients with irritable bowel syndrome: evaluating efficacy and mechanism of change
    Mohsenabadi, Hamid, Zanjani, Zahra, Shabani, Mohammad Javad, Arj, Abbas · 2018 · Journal of Psychosomatic Research
  72. Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission
    Arta Aliu, Daan H. C. A. Bosch, Dániel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean‐Frédéric Colombel, Rachel Sawyer, Hans Törnblom, Ailsa L Hart, Daisy M.A.E. Jonkers, Marieke J. Pierik et al. · 2024 · Alimentary Pharmacology & Therapeutics
  73. Diagnosis and management of irritable bowel syndrome: a guide for the generalist
    Ecushla Linedale, Jane Mary Andrews · 2017 · The Medical Journal of Australia
  74. Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis
    Chao-Rong Xie, Bin Tang, Yunzhou Shi, Wen-Yan Peng, Kun Ye, Qingfeng Tao, Shuguang Yu, Hui Zheng, Min Chen · 2022 · Frontiers in Pharmacology
  75. Pilot Study of Functional Magnetic Resonance Imaging Responses to Somatic Pain Stimuli in Youth With Functional and Inflammatory Gastrointestinal Disease
    Jeannie S. Huang, Laura Terrones, Alan N. Simmons, Walter H. Kaye, Irina A. Strigo · 2016 · Journal of Pediatric Gastroenterology and Nutrition
  76. Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents
    Yvonne Tse, David Armstrong, Christopher N. Andrews, Alain Bitton, Brian L. Bressler, John Kenneth Marshall, Louis W. C. Liu · 2017 · Canadian Journal of Gastroenterology and Hepatology
  77. Consenso mexicano sobre el síndrome de intestino irritable
    Ramón Carmona-Sánchez, María Eugenia Icaza-Chávez, M.V. Bielsa-Fernández, Octavio Gomez-Escudero, Francisco Bosques‐Padilla, Enrique Coss‐Adame, F. Esquivel-Ayanegui, Ángel Ricardo Flores-Rendón, M.A. González-Martínez, Francisco M. Huerta-Iga et al. · 2016 · Revista de Gastroenterología de México
  78. Treatment of irritable bowel syndrome
    Chamara Basnayake · 2018 · Australian Prescriber
  79. Opioid medication use in patients with gastrointestinal diagnoses vs unexplained gastrointestinal symptoms in the US Veterans Health Administration
    Gregory S. Sayuk, Navya D. Kanuri, Chandra Prakash Gyawali, Britt M. Gott, Billy Darren Nix, Robert Alan Rosenheck · 2018 · Alimentary Pharmacology & Therapeutics
  80. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease
    Mikocka-Walus, Antonina, Prady, Stephanie L, Pollok, Justyna, Esterman, Adrian J, Gordon, Andrea L, Knowles, Simon, Andrews, Jane M · 2019 · Cochrane Database of Systematic Reviews
  81. Pilot-RCT of an integrative group therapy for patients with refractory irritable bowel syndrome (ISRCTN02977330)
    Sabrina Berens, Esther Stroe‐Kunold, F. Kraus, Jonas Tesarz, Annika Gauss, Beate Niesler, Wolfgang Herzog, Rainer Schaefert · 2017 · Journal of Psychosomatic Research
  82. The physiological and psychological effects of cognitive behavior therapy on patients with inflammatory bowel disease before COVID-19: a systematic review
    Jie Chen, Xuejie Chen, Yuhao Sun, Ying Xie, Xiaoyan Wang, Ran Li, Therese M Hesketh · 2021 · BMC Gastroenterology
  83. Management of bloating
    Jordi Serra · 2022 · Neurogastroenterology & Motility
  84. Resting anal pressure, not outlet obstruction or transit, predicts healthcare utilization in chronic constipation: a retrospective cohort analysis
    Kyle D. Staller, Kenneth Barshop, Braden Kuo, Ashwin N. Ananthakrishnan · 2015 · Neurogastroenterology & Motility
  85. The Efficacy of Hypnotherapy in the Treatment of Functional Dyspepsia
    Stefan‐Lucian Popa, Giuseppe Chiarioni, Liliana David, Dan Lucian Dumitrascu · 2019 · American Journal of Therapeutics
  86. Novel pharmacological therapies for irritable bowel syndrome
    Maura Corsetti, Peter James Whorwell · 2016 · Expert Review of Gastroenterology & Hepatology
  87. Internet-Delivered Cognitive Behavior Therapy for Young Taiwanese Female Nursing Students with Irritable Bowel Syndrome—A Cluster Randomized Controlled Trial
    Tzu-Ying Lee, Tsung‐Cheng Hsieh, Huei‐Chuan Sung, Wan‐Lan Chen · 2019 · International Journal of Environmental Research and Public Health
  88. Predictors of outcome in cognitive and behavioural interventions for irritable bowel syndrome. A meta-analysis.
    Madalina Radu, R. Moldovan, S. Pintea, A. Băban, D. Dumitrascu · 2018 · Journal of Gastrointestinal and Liver Diseases
  89. Nurse-Administered, Gut-Directed Hypnotherapy in IBS: Efficacy and Factors Predicting a Positive Response
    Lövdahl, Jenny, Ringström, Gisela, Agerforz, Pia, Törnblom, Hans, Simrén, Magnus · 2015 · American Journal of Clinical Hypnosis
  90. Effects of venlafaxine on gastrointestinal symptoms, depression, anxiety, stress, and quality of life in patients with the moderate-to-severe irritable bowel syndrome
    Pardis Adhamian, MohammadReza Sharbafchi, Hamid Afshar, Awat Feizi, Hamed Daghaghzadeh, Peyman Adibi · 2020 · Journal of Research in Medical Sciences
  91. Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age
    Elyse R. Thakur, Brian M. Quigley, Hashem B. El‐Serag, Gregory D. Gudleski, Jeffrey M. Lackner · 2016 · Journal of Psychosomatic Research
  92. Perceived Stress, Its Physiological Correlates, and Quality of Life in Patients With Irritable Bowel Syndrome
    Kristen R. Weaver, Gail D’Eramo Melkus, Jason Fletcher, Wendy A. Henderson · 2018 · Biological Research For Nursing
  93. Delivery of care for functional gastrointestinal disorders: A systematic review
    Chamara Basnayake, Michael A. Kamm, Michael R Salzberg, Amy L Wilson-O'Brien, Annalise Stanley, Alexander J. V. Thompson · 2019 · Journal of Gastroenterology and Hepatology
  94. The structure of resilience in irritable bowel syndrome and its improvement through hypnotherapy: Cross-sectional and prospective longitudinal data
    Johannes Peter, Ulrich S. Tran, Maria Michalski, Gabriele Moser · 2018 · PLoS ONE
  95. Effects of Low-Dose Amitriptyline on Epigastric Pain Syndrome in Functional Dyspepsia Patients
    Jing Liu, Lin Jia, Shu-Man Jiang, Wen-cong Zhou, Yao Liu, Jian Xu · 2020 · Digestive Diseases and Sciences
  96. A pilot feasibility study of an unguided, internet‐delivered cognitive behavioral therapy program for irritable bowel syndrome
    Jocelynn T. Owusu, Alice Sibelli, Rona E Moss-Morris, Miranda A.L. van Tilburg, Rona L. Levy, Megan L. Oser · 2021 · Neurogastroenterology & Motility
  97. The Experience Sampling Method—Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorder
    Lisa Vork, Zlatan Mujagic, Marjan Drukker, Dániel Keszthelyi, José M. Conchillo, M. Hesselink, Jim van Os, Ad Masclee, Carsten Leue, Joanna W. Kruimel · 2018 · Neurogastroenterology & Motility
  98. A Review of Pharmacologic and Non-Pharmacologic Therapies in the Management of Irritable Bowel Syndrome: Current Recommendations and Evidence
    A. Papale, Robert Flattau, N. Vithlani, Deepti Mahajan, S. Nadella · 2024 · Journal of Clinical Medicine
  99. Inhibition of TRPC4 channel activity in colonic myocytes by tricyclic antidepressants disrupts colonic motility causing constipation
    Byeongseok Jeong, Tae Sik Sung, Dongju Jeon, Kyu Joo Park, Jae Yeoul Jun, Insuk So, Chansik Hong · 2022 · Journal of Cellular and Molecular Medicine
  100. Virtual Reality: A New Treatment Paradigm for Disorders of Gut-Brain Interaction?
    Brian E. Lacy, David J. Cangemi, Brennan MR Spiegel · 2023 · PubMed Central